Advertisement

Topics

Clinical Trials About "Lisdexamfetamine Placebo Bipolar Depression" RSS

21:23 EST 16th December 2018 | BioPortfolio

We list hundreds of Clinical Trials about "Lisdexamfetamine Placebo Bipolar Depression" on BioPortfolio. We draw our references from global clinical trials data listed on ClinicalTrials.gov and refresh our database daily.

More Information about "Lisdexamfetamine Placebo Bipolar Depression" on BioPortfolio

We have published hundreds of Lisdexamfetamine Placebo Bipolar Depression news stories on BioPortfolio along with dozens of Lisdexamfetamine Placebo Bipolar Depression Clinical Trials and PubMed Articles about Lisdexamfetamine Placebo Bipolar Depression for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lisdexamfetamine Placebo Bipolar Depression Companies in our database. You can also find out about relevant Lisdexamfetamine Placebo Bipolar Depression Drugs and Medications on this site too.

Showing "Lisdexamfetamine Placebo Bipolar Depression" Clinical Trials 1–25 of 22,000+

Extremely Relevant

Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression

The specific aim of this study is to evaluate the efficacy and tolerability of a stimulant (lisdexamfetamine) in the adjunctive treatment of bipolar disorder.


Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression

The specific aim of this study is to evaluate the efficacy and tolerability of lisdexamfetamine in the adjunctive treatment of bipolar disorder.

Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar Depression

The study will use neuroimaging techniques to determine whether brain activity and neurotransmitter levels are altered when lisdexamfetamine is given to subjects with bipolar disorder who are in a depressive phase. Lisdexamfetamine is a stimulant that is currently approved for attention deficit attention disorder (ADHD). The primary hypothesis is that subjects taking lisdexamfetamine will show a greater antidepressant effect than subjects taking placebo. It is also expected tha...


Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression

The study will evaluate the efficacy and safety of ITI-007 in a randomized, double-blind, parallel-group, placebo-controlled, multi-center study in patients diagnosed with Bipolar I or Bipolar II disorder having a major depressive episode.

Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally

The study will evaluate the efficacy and safety of ITI-007 in a randomized, double-blind, parallel-group, placebo-controlled, multi-center study in patients diagnosed with Bipolar I or Bipolar II disorder having a major depressive episode.

Riluzole in the Treatment of Bipolar Depression

Bipolar disorder is a common and often chronic and debilitating mental illness. The depressive phase of bipolar disorder contributes the largest portion of the disorder, and treatment resistant bipolar depression represents a significant public health problem. Recent research has suggested that bipolar depression is associated with elevated brain glutamate activity. We hypothesize that riluzole, a drug approved for ALS which inhibits glutamate activity, will lead to clinical im...

Double-Blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression

Double-Blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression Previously Diagnosed and Treated as Recurrent Major Depression: This study recruits males and females aged 18 - 70 who currently meet diagnostic criteria for bipolar I or bipolar II disorder and are currently experiencing an episode of major depression. Patients are randomized to double-blind treatment with divalproex sodium ER or placebo and remain in the study for up to six weeks. This...

Maintenance Treatment of Bipolar Depression

This study will compare two different antidepressant treatment regimens to determine which is more effective in reducing symptoms of bipolar depression.

A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression

The purpose of this study is to test a new drug, RG2417, to see how the drug affects symptoms of bipolar I depression and to make sure it is safe in humans.

Treatment Clinical Practice in Bipolar Depression in Spain

Cross-sectional observational, non interventional, multicenter study of retrospective review of clinical records of ambulatory followed up bipolar patients in order to record epidemiological aspects of the course of the disorder, more specifically of bipolar depression episodes and the clinical practices carried out by psychiatrists in Spain in bipolar depressive episodes

Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression

The study will evaluate the efficacy and safety of ITI-007 adjunctive to lithium or valproate in a randomized, double-blind, parallel-group, placebo-controlled, multi-center study in patients diagnosed with Bipolar I or Bipolar II disorder having a major depressive episode.

Levetiracetam in the Management of Bipolar Depression

A 6-week outpatient, double-blind, placebo-controlled, add-on trial to investigate the effects of levetiracetam on depressive symptoms in bipolar depressed patients.

Acute Psychotherapy for Bipolar II Depression

This proposed study is designed to compare the efficacy of interpersonal and social rhythm therapy (IPSRT) alone to IPSRT plus medication as an acute treatment for bipolar II depression. The investigators propose to conduct a randomized, controlled, trial comparing the effects of IPSRT plus pill placebo to IPSRT plus quetiapine on depressive symptoms in individuals suffering from Bipolar II depression. The investigators will also examine the impact of treatment on psychosocial...

A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression

The main goal of this study is to help answer the following research question(s) and not to treat the child's illness. - Can this study drug make children with bipolar depression feel better? - Does this study drug work better than a placebo (sugar pill)? - Does this study drug cause side effects in children who take it? - Is this drug safe to use in children? (The study drug is a mixture of olanzapine and fluoxetine)

Melancholic Symptoms in Bipolar Depression and Responsiveness to Lamotrigine

The purpose of this study is to determine if patients with melancholic bipolar II depression are more responsive to lamotrigine than patients with non-melancholic bipolar II depression. To do this, we will re-analyze a previous clinical trial that evaluated lamotrigine as a treatment for bipolar II depression (GSK-SCA100223; NCT00274677).

Probiotics to Prevent Relapse After Hospitalization for Bipolar Depression

The purpose of this study is to determine if taking a probiotic supplement versus a placebo will reduce relapse and improve the clinical course among participants who have been hospitalized for bipolar depression.

A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar Depression

The purpose of the Pilot Study Investigating the Efficacy of Minocycline and n-acetylcysteine for Bipolar Depression is to test the effectiveness of minocycline, n-acetylcysteine, and combined minocycline and n-acetylcysteine pharmacotherapy in order to fill the gap in treatments for bipolar depression. The treatment of bipolar depression remains the greatest unmet need in the management of this lifelong and chronic psychiatric disorder.

Relevant

Behavioural Activation for Bipolar Depression: A Case Series

Bipolar Disorders affect around 2% of the population. Most people with Bipolar experience depression; these periods can cause difficulties with relationships, work and daily life. Psychological therapies for "unipolar" depression (for people who experience depression but never mania or hypomania) are widely available, but there is little research in to how effective these therapies are for people with Bipolar. Knowing this could give greater choice to people with Bipolar in te...

Lurasidone Pediatric Bipolar Study

A study to evaluate efficacy and safety of flexibly dosed Lurasidone in children and adolescents with bipolar I depression

Ceftriaxone in the Management of Bipolar Depression

We aim to study the efficacy of intravenous ceftriaxone in a four-week, inpatient, placebo-controlled, double-blind study, as an augmentation therapy in patients with bipolar disorder, currently depressed, who have failed to respond to conventional treatments.

Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode

The purpose of this study is to evaluate flexible doses (5-30mg) of aripiprazole versus placebo in patients with bipolar depression.

Treatment Resistant Bipolar Depression

To determine if adding Escitalopram to current mood stabilizer (MS) or atypical antipsychotic (AA) will improve in rates similar to or better than adding a placebo (inactive pill)in resistant bipolar patients.

Olanzapine Treatment of Patients With Bipolar I Disorder

The purpose of this study is to assess whether olanzapine is superior to placebo in patients with bipolar depression.

EmSam in Bipolar Depression

This pilot study will evaluate the efficacy of the monoamine oxidase inhibitor (MAOI)Ensam, a selegiline transdermal system (STS), in bipolar depression.

NRX100 vs. Placebo for Stabilization of Acute Suicidal Ideation an Behavior in Bipolar Depression

NMDA antagonist drugs have increasingly been demonstrated to reduce symptoms of depression and suicidal ideation. NeuroRx has developed a sequential therapy consisting of IV NRX-100 (ketamine HCL) for rapid stabilization of symptoms of depression and suicidal ideation followed by oral NRX-101 (fixed dose combination of D-cycloserine and lurasidone) for maintenance of stabilization from symptoms of depression and suicidal ideation. This study will test the hypothesis that that N...


More From BioPortfolio on "Lisdexamfetamine Placebo Bipolar Depression"

Advertisement
Quick Search
Advertisement
Advertisement